Rare Cancers – more common than you think
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
25 Feb 2015
Press Release: Rare Disease Day 2015 - Living With A Rare Cancer
Rare Disease Day 2015 seeks to raise awareness of the challenges faced by patients and their families
24 Feb 2015
Interview with RCE Chair Paolo Casali in Innovations in Oncology Report
'Success with orphan drugs needn't be rare'
18 Feb 2015
FDA Approves Lenvatinib for Differentiated Thyroid Cancer Refractory to Iodine-131
Offering a new treatment paradigm for a group of patients for whom, until recently, there has been no new effective treatment since the 1940s.